Final Results Published, Brazilian Pharmacopeia Selection, 2026-2031 Committees

Mon, 20 Apr 2026 16:57:19 +0000
Pharmaceuticals

ANVISA published the final results of the 2026 selection process for the Brazilian Pharmacopeia (Farmacopeia Brasileira), including appeal evaluation outcomes, overall scores, and results by committee. Selected candidates will compose the Technical Thematic Committees that will operate from 2026 to 2031. The Brazilian Pharmacopeia establishes minimum quality, authenticity, and purity requirements for pharmaceutical inputs, medicines, and other health-surveillance products.